Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study

• Comparing Hemostatic Efficacy of Four-factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-treated Polytrauma Male Porcine Model

  2026 Anesthesiology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation Open access

  1

  citations
• Andexanet alfa for the reversal of anticoagulation: Dutch practice data

  2026 Research and Practice in Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access

  0

  citations
• Diagnostics and management of direct oral anticoagulants–induced bleeding

  2025 Current Opinion in Anaesthesiology article Medicine Atrial Fibrillation Management and Outcomes

  0

  citations
• Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors

  2024 Journal of Thrombosis and Haemostasis article Medicine Blood Coagulation and Thrombosis Mechanisms Open access cited by 1 patent

  5

  citations
• Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding

  2024 European Journal of Anaesthesiology article Medicine Atrial Fibrillation Management and Outcomes Open access

  45

  citations
• Antidote vs. unspecific hemostatic agents for the management of direct oral anticoagulant-related bleeding in trauma

  2024 Current Opinion in Anaesthesiology article Medicine Atrial Fibrillation Management and Outcomes

  6

  citations
• Reversing Rivaroxaban Anticoagulation as Part of a Multimodal Hemostatic Intervention in a Polytrauma Animal Model

  2021 Anesthesiology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation

  11

  citations
• Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis

  2021 Critical Care Medicine review Medicine Atrial Fibrillation Management and Outcomes

  60

  citations
• A meta‐analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor–related major bleeding

  2021 Research and Practice in Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access

  23

  citations
• Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists

  2020 Thrombosis Research article Medicine Intracerebral and Subarachnoid Hemorrhage Research Open access

  1

  citations
• Evaluation of oral factor Xa inhibitor‐associated extracranial bleeding reversal with andexanet alfa

  2020 Journal of Thrombosis and Haemostasis article Medicine Atrial Fibrillation Management and Outcomes Open access

  26

  citations
• Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies

  2020 Seminars in Thrombosis and Hemostasis article Medicine Blood Coagulation and Thrombosis Mechanisms Open access

  15

  citations

12 results